The progress and future of the treatment of Candida albicans infections based on nanotechnology
Y Gao, Q Cao, Y Xiao, Y Wu, L Ding, H Huang… - Journal of …, 2024 - Springer
Systemic infection with Candida albicans poses a significant risk for people with weakened
immune systems and carries a mortality rate of up to 60%. However, current therapeutic …
immune systems and carries a mortality rate of up to 60%. However, current therapeutic …